Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

被引：13

作者：

Watanabe, Ryu ^{[1
]}

Ishii, Tomonori ^{[1
]}

Araki, Kyoko ^{[1
]}

Ishizuka, Mariko ^{[1
]}

Kamogawa, Yukiko ^{[1
]}

Fujita, Yoko ^{[1
]}

Shirota, Yuko ^{[1
]}

Fujii, Hiroshi ^{[1
]}

Harigae, Hideo ^{[1
]}

机构：

[1] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan

来源：

MODERN RHEUMATOLOGY | 2016年 / 26卷 / 03期

关键词：

Clinically amyopathic dermatomyositis; Interstitial lung disease; Multi-target therapy; Rituximab; ANTIBODY;

D O I：

10.3109/14397595.2015.1012797

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：465 / 466

页数：2

共 50 条

[11] A Fatal Case of Rapidly Progressive Interstitial Lung Disease Associated with Clinically Amyopathic Dermatomyositis
Manglani, R. P.
Lee, K.
Epelbaum, O.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[12] Rapidly Progressive Interstitial Lung Disease Associated with Amyopathic Dermatomyositis
Tandon, V. O.
Nadler, E.
Tandon, A.
Manek, G.
Grover, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[13] Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis
Zhu, Dingxian
Qiao, Jianjun
Tang, Shunli
Pan, Yunlei
Li, Sheng
Yang, Changyi
Fang, Hong
RHEUMATOLOGY, 2021, 60 (08) : 3896 - 3903
[14] Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis
Y. Xu
C. S. Yang
Y. J. Li
X. D. Liu
J. N. Wang
Q. Zhao
W. G. Xiao
P. T. Yang
Clinical Rheumatology, 2016, 35 : 113 - 116
[15] Predictive factors of rapidly progressive-interstitial lung disease in patients with clinically amyopathic dermatomyositis
Xu, Y.
Yang, C. S.
Li, Y. J.
Liu, X. D.
Wang, J. N.
Zhao, Q.
Xiao, W. G.
Yang, P. T.
CLINICAL RHEUMATOLOGY, 2016, 35 (01) : 113 - 116
[16] A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
Toshinori Takada
Katsuaki Asakawa
Roberto Barrios
Clinical Rheumatology, 2021, 40 : 1159 - 1165
[17] A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis
Takada, Toshinori
Asakawa, Katsuaki
Barrios, Roberto
CLINICAL RHEUMATOLOGY, 2021, 40 (03) : 1159 - 1165
[18] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ANTI-MDA5-RELATED CLINICALLY AMYOPATHIC DERMATOMYOSITIS
Cardenas, Carlos
Gupta, Surbhi
Kim, Jaehyun
Kershaw, Corey
Tomlinson, Andrew
CHEST, 2019, 156 (04) : 1867A - 1868A
[19] Anti-MDA5 Associated Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease
Tavakolian, Kameron
Odak, Mihir
Mararenko, Anton
Ilagan, Justin
Douedi, Steven
Khan, Taimoor
Al Saoudi, Ghadier
JOURNAL OF MEDICAL CASES, 2022, 13 (08) : 374 - 379
[20] Successful Application of Rituximab and ECMO in a Patient with Rapidly Progressive Interstitial Lung Disease Related to Anti-MDA-5 Antibody Positive Amyopathic Dermatomyositis
Singh, H.
Safi, J.
Raz, Y.
LaCamera, P.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197

← 1 2 3 4 5 →